Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.297NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
AH.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.280NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.597NWon-NGTTGCGACTACGTGATGAGG20552884928830R-18062.4South Korea
B.1.177.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.72NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.85NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.66 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.72 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.133 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.7 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.33.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.493NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.351.2 (Beta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.640.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.352NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.251NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XCJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FT.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.48NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EK.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GS.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.21.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EE.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ES.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.19.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.479NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.437NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HU.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JC.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.625NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used